FGF4 and breast carcinoma: Being intravenously injected in tumor-bearing mice, those chimeric peptides suppressed the growth of murine breast carcinoma EF43-fgf4, while the cancer cell surface-expressed GRP78, as the peptide-targeted receptor, ensured the cell death-driving internalization [218].